APA (7th ed.) Citation

MK, M., R, D., H, S., S, I., M, S., A, L., . . . L, O. (2013). CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis. United European gastroenterology journal, 1(6), 467. https://doi.org/10.1177/2050640613502962

Chicago Style (17th ed.) Citation

MK, Magnusson, Dahlén R, Strid H, Isaksson S, Simrén M, Lasson A, Bajor A, Ung KA, and Ohman L. "CD25 and TNF Receptor II Reflect Early Primary Response to Infliximab Therapy in Patients with Ulcerative Colitis." United European Gastroenterology Journal 1, no. 6 (2013): 467. https://doi.org/10.1177/2050640613502962.

MLA (9th ed.) Citation

MK, Magnusson, et al. "CD25 and TNF Receptor II Reflect Early Primary Response to Infliximab Therapy in Patients with Ulcerative Colitis." United European Gastroenterology Journal, vol. 1, no. 6, 2013, p. 467, https://doi.org/10.1177/2050640613502962.